Increased levels of serum and tissue MIR-107 in human gastric cancer: Correlation with tumor hypoxia

Cancer Biomarkers

Volumn 15, Issue 6, 2015, Pages 851-860

  Ayremlou, Nooshin ^a   Mozdarani, Hossein ^a   Mowla, Seyed Javad ^a   Delavari, Alireza ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gastric cancer; hypoxia; MIR 107

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA 107; HIF1A PROTEIN, HUMAN; MICRORNA; MIRN107 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYPOXEMIA; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RNA ANALYSIS; STOMACH CANCER; TISSUE LEVEL; TUMOR DIFFERENTIATION; UPREGULATION; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; HYPOXIA; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; STOMACH TUMOR;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; STOMACH NEOPLASMS;

EID: 84949185691     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-150529     Document Type: Article

References (55)

1. J. D. Arroyo, J. R. Chevillet, E. M. Kroh, I. K. Ruf, C. C. Pritchard, D. F. Gibson, P. S. Mitchell, C. F. Bennett, E. L. Pogosova-Agadjanyan, D. L. Stirewalt et al, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proceedings of the National Academy of Sciences of the United States of America 108(2011), 5003-5008.
2. M. Blanco-Calvo, L. Calvo, A. Figueroa, M. Haz-Conde, L. Anton-Aparicio, M. Valladares-Ayerbes, Circulating microRNAs: Molecular microsensors in gastrointestinal cancer, Sensors 12(2012), 9349-9362.
3. C. Blenkiron, L. D. Goldstein, N. P. Thorne, I. Spiteri, S. F. Chin, M. J. Dunning, N. L. Barbosa-Morais, A. E. Teschendorff, A. R. Green, I. O. Ellis et al, MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype, Genome Biology 8(2007), R214.
4. M. Bloomston, W. L. Frankel, F. Petrocca, S. Volinia, H. Alder, J. P. Hagan, C. G. Liu, D. Bhatt, C. Taccioli, C. M. Croce, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis, JAMA 297(2007), 1901-1908.
5. J. M. Brown, A. J. Giaccia, The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy, Cancer Research 58(1998), 1408-1416.
6. R. J. Bryant, T. Pawlowski, J. W. Catto, G. Marsden, R. L. Vessella, B. Rhees, C. Kuslich, T. Visakorpi, F. C. Hamdy, Changes in circulating microRNA levels associated with prostate cancer, British Journal of Cancer 106(2012), 768-774.
7. M. Carleton, M. A. Cleary, P. S. Linsley, MicroRNAs and cell cycle regulation, Cell Cycle 6(2007), 2127-2132.
8. H. Y. Chen, Y. M. Lin, H. C. Chung, Y. D. Lang, C. J. Lin, J. Huang, W. C. Wang, F. M. Lin, Z. Chen, H. D. Huang et al, miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4, Cancer Research 72(2012), 3631-3641.
9. P. S. Chen, J. L. Su, S. T. Cha, W. Y. Tarn, M. Y. Wang, H. C. Hsu, M. T. Lin, C. Y. Chu, K. T. Hua, C. N. Chen et al, miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans, The Journal of Clinical Investigation 121(2011), 3442-3455.
10. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo et al, Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases, Cell Research 18(2008), 997-1006.
11. L. Cicatiello, M. Mutarelli, O. M. Grober, O. Paris, L. Ferraro, M. Ravo, R. Tarallo, S. Luo, G. P. Schroth, M. Seifert et al, Estrogen receptor alpha controls a gene network in luminallike breast cancer cells comprising multiple transcription factors and microRNAs, The American Journal of Pathology 176(2010), 2113-2130.
12. M. E. Crosby, C. M. Devlin, P. M. Glazer, G. A. Calin, M. Ivan, Emerging roles of microRNAs in the molecular responses to hypoxia, Current Pharmaceutical Design 15(2009), 3861-3866.
13. J. Datta, A. Smith, J. C. Lang, M. Islam, D. Dutt, T. N. Teknos, Q. Pan, microRNA-107 functions as a candidate tumorsuppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cvarepsilon, Oncogene 31(2012), 4045-4053.
14. A. Esquela-Kerscher, F. J. Slack, Oncomirs - microRNAs with a role in cancer, Nature Reviews Cancer 6(2006), 259-269.
15. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, D. M. Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, International Journal of Cancer Journal International Du Cancer 127(2010), 2893-2917.
16. W. Filipowicz, S. N. Bhattacharyya, N. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nature Reviews Genetics 9(2008), 102-114.
17. R. Garzon, G. A. Calin, C. M. Croce, MicroRNAs in cancer, Annual Review of Medicine 60(2009), 167-179.
18. H. E. Gee, C. Ivan, G. A. Calin, M. Ivan, HypoxamiRs and cancer: From biology to targeted therapy, Antioxidants and redox signaling 21(2014), 1220-1238.
19. F. Gottardo, C. G. Liu, M. Ferracin, G. A. Calin, M. Fassan, P. Bassi, C. Sevignani, D. Byrne, M. Negrini, F. Pagano et al, Micro-RNA profiling in kidney and bladder cancers, Urologic Oncology 25(2007), 387-392.
20. Y. Guo, Z. Chen, L. Zhang, F. Zhou, S. Shi, X. Feng, B. Li, X. Meng, X. Ma, M. Luo et al, Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma, Cancer Research 68(2008), 26-33.
21. A. L. Harris, Hypoxia - a key regulatory factor in tumour growth, Nature Reviews Cancer 2(2002), 38-47.
22. S. D. Hatfield, H. R. Shcherbata, K. A. Fischer, K. Nakahara, R. W. Carthew, H. Ruohola-Baker, Stem cell division is regulated by the microRNA pathway, Nature 435(2005), 974-978.
23. A. S. Ho, X. Huang, H. Kao, C. Cristmas-Skieller, K. Bennewith, Q. Le, A. Koong, Circulating miR-210 as a novel hypoxia marker in pancreatic cancer, Translational Oncology 3(2010), 109-113.
24. X. H. Huang, Q. Wang, J. S. Chen, X. H. Fu, X. L. Chen, L. Z. Chen, W. Li, J. Bi, L. J. Zhang, Q. Fu et al, Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: MiR-338 is downregulated, Hepatology Research: The Official Journal of the Japan Society of Hepatology 39(2009), 786-794.
25. H. W. Hwang, J. T. Mendell, MicroRNAs in cell proliferation, cell death, and tumorigenesis, British Journal of Cancer 94(2006), 776-780.
26. T. Inoue, H. Iinuma, E. Ogawa, T. Inaba, R. Fukushima, Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer, Oncology Reports 27(2012), 1759-1764.
27. M. Ivan, A. L. Harris, F. Martelli, R. Kulshreshtha, Hypoxia response and microRNAs: No longer two separate worlds, Journal of Cellular and Molecular Medicine 12(2008), 1426-1431.
28. M. Jovanovic, M. O. Hengartner, miRNAs and apoptosis: RNAs to die for, Oncogene 25(2006), 6176-6187.
29. M. Kobayashi, K. Nakagawa, Metastasis and hypoxiainducible factor, Gan to Kagaku Ryoho Cancer and Chemotherapy 37(2010), 2047-2051.
30. R. Kulshreshtha, M. Ferracin, S. E. Wojcik, R. Garzon, H. Alder, F. J. Agosto-Perez, R. Davuluri, C. G. Liu, C. M. Croce, M. Negrini et al, A microRNA signature of hypoxia, Molecular and Cellular Biology 27(2007), 1859-1867.
31. K. L. Lan, K. H. Lan, M. L. Sheu, M. Y. Chen, Y. S. Shih, F. C. Hsu, H. M. Wang, R. S. Liu, S. H. Yen, Honokiol inhibits hypoxia-inducible factor-1 pathway, International Journal of Radiation Biology 87(2011), 579-590.
32. K. H. Lee, C. Lotterman, C. Karikari, N. Omura, G. Feldmann, N. Habbe, M. G. Goggins, J. T. Mendell, A. Maitra, Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer, Pancreatology: Official Journal of the International Association of Pancreatology 9(2009), 293-301.
33. F. Li, B. Liu, Y. Gao, Y. Liu, Y. Xu, W. Tong, A. Zhang, Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1, FEBS Letters 588(2014), 538-544.
34. X. Li, Y. Zhang, Y. Shi, G. Dong, J. Liang, Y. Han, X. Wang, Q. Zhao, J. Ding, K. Wu, D. Fan, MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer, Journal of Cellular and Molecular Medicine 15(2011), 1887-1895.
35. X. Y. Li, Q. F. Luo, C. K. Wei, D. F. Li, J. Li, L. Fang, MiRNA- 107 inhibits proliferation and migration by targeting CDK8 in breast cancer, International Journal of Clinical and Experimental Medicine 7(2014), 32-40.
36. Z. H. Li, H. Zhang, Z. G. Yang, G. Q. Wen, Y. B. Cui, G. G. Shao, Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer, The Journal of International Medical Research 41(2013), 1437-1444.
37. P. S. Mitchell, R. K. Parkin, E. M. Kroh, B. R. Fritz, S. K. Wyman, E. L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K. C. O'Briant, A. Allen, et al, Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences of the United States of America 105(2008), 10513-10518.
38. Y. Murakami, T. Yasuda, K. Saigo, T. Urashima, H. Toyoda, T. Okanoue, K. Shimotohno, Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues, Oncogene 25(2006), 2537-2545.
39. S. Nallamshetty, S. Y. Chan, J. Loscalzo, Hypoxia: A master regulator of microRNA biogenesis and activity, Free Radical Biology and medicine 64(2013), 20-30.
40. M. Ozen, C. J. Creighton, M. Ozdemir, M. Ittmann, Widespread deregulation of microRNA expression in human prostate cancer, Oncogene 27(2008), 1788-1793.
41. C. C. Pritchard, E. Kroh, B. Wood, J. D. Arroyo, K. J. Dougherty, M. M. Miyaji, J. F. Tait, M. Tewari, Blood cell origin of circulating microRNAs: A cautionary note for cancer biomarker studies, Cancer Prevention Research 5(2012), 492-497.
42. C. Roldo, E. Missiaglia, J. P. Hagan, M. Falconi, P. Capelli, S. Bersani, G. A. Calin, S. Volinia, C. G. Liu, A. Scarpa, C. M. Croce, MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(2006), 4677-4684.
43. P. Rotkrua, S. Shimada, K. Mogushi, Y. Akiyama, H. Tanaka, Y. Yuasa, Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model, British Journal of Cancer 108(2013), 932-940.
44. S. Sassen, E. A. Miska, C. Caldas, MicroRNA: Implications for cancer, Virchows Archiv: An International Journal of Pathology 452(2008), 1-10.
45. T. Schepeler, J. T. Reinert, M. S. Ostenfeld, L. L. Christensen, A. N. Silahtaroglu, L. Dyrskjot, C. Wiuf, F. J. Sorensen, M. Kruhoffer, S. Laurberg et al, Diagnostic and prognostic microRNAs in stage II colon cancer, Cancer Research 68(2008), 6416-6424.
46. P. Sharma, A. Saraya, P. Gupta, R. Sharma, Decreased levels of circulating and tissue miR-107 in human esophageal cancer, Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 18(2013), 322-330.
47. M. Stock, F. Otto, Gene deregulation in gastric cancer, Gene 360(2005), 1-19.
48. Y. P. Tsai, K. J. Wu, Hypoxia-regulated target genes implicated in tumor metastasis, Journal of Biomedical Science 19(2012), 102.
49. S. Volinia, G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin et al, A microRNA expression signature of human solid tumors defines cancer gene targets, Proceedings of the National Academy of Sciences of the United States of America 103(2006), 2257-2261.
50. M. J. Voss, B. Niggemann, K. S. Zanker, F. Entschladen, Tumour reactions to hypoxia, Current Molecular Medicine 10(2010), 381-386.
51. K. J. Williams, C. A. Parker, I. J. Stratford, Exogenous and endogenous markers of tumour oxygenation status: Definitive markers of tumour hypoxia? Advances in Experimental Medicine and Biology 566(2005), 285-294.
52. M. Yamakuchi, C. D. Lotterman, C. Bao, R. H. Hruban, B. Karim, J. T. Mendell, D. Huso, C. J. Lowenstein, P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis, Proceedings of the National Academy of Sciences of the United States of America 107(2010), 6334-6339.
53. N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R. M. Stephens, A. Okamoto, J. Yokota, T. Tanaka et al, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell 9(2006), 189-198.
54. W. Yasui, H. Yokozaki, J. Fujimoto, K. Naka, H. Kuniyasu, E. Tahara, Genetic and epigenetic alterations in multistep carcinogenesis of the stomach, Journal of Gastroenterology 35 Suppl 12(2000), 111-115.
55. H. Zhou, J. M. Guo, Y. R. Lou, X. J. Zhang, F. D. Zhong, Z. Jiang, J. Cheng, B. X. Xiao, Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker, Journal of Molecular Medicine 88(2010), 709-717.